A prospective natural-history study of coronary atherosclerosis.
By Gregg Stone, A. Maehara, A. Lansky, B. de Bruyne, E. Cristea, G. Mintz, R. Mehran, J. Mcpherson, Naim Z. Farhat, S. Marso and 5 more. New England Journal of Medicine, 2011
3,139 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/39cc59cee0212213e01b7e72f121b7e851c10ad4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
In Radiology, Nuclear Medicine and Imaging
In Surgery
Citations in the corpus
- Low-dose colchicine for secondary prevention of cardiovascular disease. (2013, positive): “It would be of special interest to examine the value of initiating colchicine in patients recently hospitalized for ACS because they remain at particularly high risk of recurrent events for several months due to disruption of both culprit and nonculprit plaques (19).”
- Update on acute coronary syndromes: the pathologists' view. (2013, background): “PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) was the first and is the largest natural-history study of coronary atherosclerosis using multimodality intracoronary imaging to identify vulnerable plaques to date.(115)”
- 2018 ESC/EACTS Guidelines on myocardial revascularization. (2019, neutral): “Patients with symptomatic disease progression after PCI account for up to 50% of reinterventions.(383,384) They should be managed using criteria similar to those applied to patients without previous revascularization.”
- Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-Up. (2015, background): “Although the presence of PR and LAP was associated with the development of acute coronary syndrome (ACS) during 2-year follow-up in our previous study (10), the mid-term prognosis on the basis of CTA findings has not been reported.”
- Contemporary Reviews in Cardiovascular Medicine The Assessment of Endothelial Function From Research Into Clinical Practice (2012, neutral): “Au sein de ces segments, l’activité du NO est déprimée alors que celle de l’endothéline 1 est augmentée,(138) ces mêmes segments étant, par ailleurs, ceux dont les lésions risquent le plus d’évoluer vers une forme obstructive.(139) Surtout, la dysfonction microvasculaire peut concourir à altérer la ”